Full history for every metric is available with a Kvantra account
Life Science REIT plc (LABS.L)
Key financial summary
Financials in GBP| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | £m | - | - | 1 | 16 | 20 | 20 | 21 |
| Operating profit | £m | 10 | 9 | |||||
| Net profit | £m | - | - | 8 | -28 | -22 | -14 | -31 |
| EPS reported | £ | -0.04 | -0.09 | |||||
| Operating cashflow per share | £ | 0.04 | 0.04 | |||||
| Capex per share | £ | 0.06 | 0.06 | |||||
| FCF per share | £ | -0.02 | -0.02 | |||||
| Free cash flow | £m | -6 | -2 | |||||
| Net debt | £m | 117 | 122 | |||||
| Book value equity | £m | 263 | 233 | |||||
| Book value per share | £ | 0.75 | 0.67 | |||||
| Number of shares | m | 350 | 350 | |||||
| DPS (TTM paid) | £ | 0.01 | 0.00 |
Financial summary
Financials in GBP| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 0.51 | 0.65 | |||||
| P/S LTM | x | 6.55 | 7.17 | |||||
| P/FCF LTM | x | -20.92 | -87.75 | |||||
| EV/EBITDA LTM | x | 25.53 | 29.74 | |||||
| EV/Sales LTM | x | 12.29 | 12.95 | |||||
| Earnings Yield LTM | % | -10.51% | -9.27% | |||||
| FCF Yield | % | -4.78% | -1.14% | |||||
| Quality | ||||||||
| ROE | % | -5.32% | -5.11% | |||||
| ROIC | % | 123.11% | 123.11% | |||||
| Operating margin | % | 48.16% | 48.16% | |||||
| Gross margin | % | 56.36% | 56.36% | |||||
| FCF/Sales | % | -31.31% | -31.31% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +1.84% | +4.55% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | -0.08% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 5.26% | 0.33% | |||||
| Dividend Growth | % | -50.00% | - | |||||
| Payout Ratio | % | -50.08% | -50.08% | |||||
| FCF/Debt | x | -0.05 | -0.01 | |||||
| Net Debt/EBITDA | x | 11.93 | 11.93 | |||||
| EBIT/Net interest | x | 1.06 | 1.06 | |||||
| Net debt/market cap | % | 87.72% | 80.66% | |||||
| Net debt/Equity | x | 0.44 | 0.52 | |||||
| Gross debt/equity | x | 0.47 | 0.54 | |||||
Company overview
Life Science REIT Plc functions as an investment enterprise, with the intention of operating as a Real Estate Investment Trust (REIT). This company, which commenced operations on July 27, 2021, from its headquarters in London, United Kingdom, aims to offer its shareholders a compelling aggregate return.
Similar companies
- Prospect Logistics and Industrial Freehold and Leasehold Real Estate Investment Trust
- Daiwa House Logistics Trust
- SF Real Estate Investment Trust
- WHA Industrial Leasehold Real Estate Investment Trust
- AIM Industrial Growth Freehold and Leasehold Real Estate Investment Trust
- Pro Real Estate Investment Trust
- Amata Summit Growth Freehold and Leasehold Real Estate Investment Trust
- Terra Property Trust, Inc.
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Life Science REIT plc (LABS.L)
Life Science REIT Plc functions as an investment enterprise, with the intention of operating as a Real Estate Investment Trust (REIT). This company, which commenced operations on July 27, 2021, from its headquarters in London, United Kingdom, aims to offer its shareholders a compelling aggregate return.
- Prospect Logistics and Industrial Freehold and Leasehold Real Estate Investment Trust
- Daiwa House Logistics Trust
- SF Real Estate Investment Trust
- WHA Industrial Leasehold Real Estate Investment Trust
- AIM Industrial Growth Freehold and Leasehold Real Estate Investment Trust
- Pro Real Estate Investment Trust
- Amata Summit Growth Freehold and Leasehold Real Estate Investment Trust
- Terra Property Trust, Inc.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free